Synthesis and biological evaluation of clovamide analogues with catechol functionality as potent Parkinson’s disease agents in vitro and in vivo
作者:Jia-Hao Feng、Xiao-Long Hu、Xian-Yu Lv、Bao-Lin Wang、Jun Lin、Xiao-Qi Zhang、Wen-Cai Ye、Fei Xiong、Hao Wang
DOI:10.1016/j.bmcl.2018.11.030
日期:2019.1
• In this study, seven clovamide analogues (1–7) were designed and synthesized, and the neuroprotection of 1–7 as well as 8–15 (prepared in our previous work) against H2O2-induced oxidative stress was evaluated in SH-SY5Y cells. Results showed that 1–7 with catechol groups exhibited better neuroprotective effects than 8–15, and their EC50 values ranged from 4.26 to 23.83 μM, especially 1, indicating
• 在这项研究中,设计并合成了7种氯仿酰胺类似物(1 – 7),并在SH中评估了1 – 7以及8 – 15(在我们先前的工作中制备)对H 2 O 2诱导的氧化应激的神经保护作用。-SY5Y细胞。结果表明,1 - 7与儿茶酚基团表现出比更好的神经保护作用8 - 15,以及它们的EC 50值从4.26到不等23.83μM,特别是1,表明邻苯二酚的部分支配了这些化合物的活性。此外,口服1(10或20 mg / kg)被证明具有通过减轻体内和体外细胞凋亡和氧化应激以及上调血红素加氧酶-1(HO-1)的表达而具有抗PD的作用。 )通过PI3K / AKT / mTOR途径进行。最后,在大鼠中确定1的药代动力学(PK)评估。这些发现表明1可能是PD治疗的有效候选者。